Once the company application for the FDA orphan drug destination is approved. This stock could sky rocket to $1 level. At which time, we'll have true large partnership coming on board and push the company to the next level. The prospect is getting brighter and brighter everyday. I would hold onto your shares as long as possible and don't let the shorts scare you of selling out to soon. The run up is just beginning.
Anyone have any idea the average approval time frame for orphan drug destination status. Anyway, I've read in the past that the company expect some answer between Jan. and Feb. 2013. Anyone can confirm this?